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Abstract
Re-expansion pulmonary edema (RPE) is an acute, rare and potentially lethal complication [1,2]. Its
beginning is sudden and dramatic. The mechanism is not yet fully understood [1]. Some authors
suggest that it may occur after rapid re-inflation of a collapsed lung [1]. It was reported by other
authors that it may relate to surfactant depletion or may result from hypoxic capillary damage,
leading to increased capillary permeability [1,3]. In RPE, unilateral lung injury is initiated by cytotoxic
oxygen metabolites and temporally associated with an influx of polymorphonuclear neutrophils [1].
These toxic oxygen products are the results of re-oxygenation of a collapsed lung. Treatment of
re-expansion pulmonary edema is basically preventive [4].
Introduction
Re-expansion pulmonary edema (RPE) is an acute, rare
and potentially lethal complication [1,2]. Its beginning is
sudden and dramatic. The mechanism is not yet fully
understood [1]. Some authors suggest that it may occur
after rapid re-inflation of a collapsed lung [1]. It was
reported by other authors that it may relate to surfactant
depletion or may result from hypoxic capillary damage,
leading to increased capillary permeability [1,3]. In RPE,
unilateral lung injury is initiated by cytotoxic oxygen
metabolites and temporally associated with an influx of
polymorphonuclear neutrophils [1]. These toxic oxygen
products are the results of re-oxygenation of a collapsed
lung. Treatment of re-expansion pulmonary edema is
basically preventive [4].
The RPE is a disease process that is characterized by diffuse
inflammation in the lung parenchyma and resultant per-
meability edema [2]. The involvement of inflammatory
mediators in RPE has been the subject of intense investi-
gation, and oxidant-mediated tissue injury is likely to be
important in the pathogenesis of RPE [2]. In response to
various inflammatory stimuli, lung endothelial cells, alve-
olar cells, and airway epithelial cells, as well as alveolar
macrophages, produce reactive oxygen species (ROS)
[2,5]. Free oxygen radicals increase after pulmonary re-
expansion and, it can enhance the production of these
toxic species [2,5]. As the antioxidant defense system, var-
ious enzymes and low-molecular weight ROS scavengers
are present in the lung tissue and epithelial lining fluid
[2,5].
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Taurine, 2-amino ethane sulfonic acid, is a normal con-
stituent of the human diet and is a ubiquitous powerful
antioxidant [6]. It prevents tissue injury mainly through
antioxidation [6]. Taurine was revealed to be beneficial in
preventing experimental lead-induced oxidative damage,
diabetic neuropathy, CCl4-induced oxidative stress, cae-
urelein-induced acute pancreatitis, and early changes in
experimental diabetic kidney through antioxidant mecha-
nisms [6-8]. In bleomycine-induced lung injury and
glomerular basal membrane damage caused by stimu-
lated neutrophils which may be activated by oxidative
stress and preventive effect of taurine were reported [7].
Previous studies have shown that taurine exhibits a pro-
tective effect against cellular-stress induced oxidation
[8,14]. Indeed, taurine behaves as a free radical scavenger
in various cells and tissues [9-11,14]. The protective
effects of taurine against cytotoxicity and oxidative stress
have been observed in cells and tissues, both in vivo and
in vitro [8,9,11,14]. Since we think that cytotoxic oxygen
metabolites are important in the mechanism of RPE, we
aimed to investigate the possible beneficial protective
effects of taurine in RPE in rats.
Materials and methods
The study was performed in Gulhane Military Medical
Academy (GMMA) Animal Research Laboratory. GMMA
Ethics committee's permission was obtained before the
study.
Specifications of Laboratory Animals
In this study, 21 adult Spraque-Dawley rats (weighing:
150 +/- 20 g) were used. Prior to the initiation of the
experiment, all animals were provided access to the same
feed (2650 kkal/kg metabolic energy, 22% protein, 8%
cellulose, and fat 8% and water in the same environment,
20–22°C) for a period of 7 days.
Experimental design
21 adult rats were subdivided into three groups by the
simple random sampling method. The first group was the
control group (CG), the second group was RPE group
(RPEG) and the third group was RPE plus taurine group
(TG). All animals were subject to the same experimental
protocol. RPE or PA wasn't performed in CG. The RPE was
performed in RPEG and TG. In addition, TG was given
taurine containing diet.
Antioxidant Agent Application
TG was given taurine (200 mg/kg rat body weight) con-
taining solution orally by gavage.
The RPE procedure is explained below in details.
The RPE Procedure
Rats were anesthetized with intraperitoneal Ketamine
Hydrocloride (Ketamine hydrochloride solution in %5,
Parke – Davis license Eczacıbas ¸ı Medical Industry, Ýstan-
bul) 90 mg/kg and Xylazine (Xylazine solution in %2, by
Parke – Davis license Eczacıbas ¸ı Medical Industry, Ýstan-
bul, 10 mg/kg). 200 mg taurine was diluted with 3 ml of
0.9% NaCl solution. In TG, taurine administration was
started 8 h before pneumothorax application and contin-
ued for 72 hours by gavage.
All rats' right chest walls were shaved. In RPEG and TG,
pneumothorax was induced by injecting about 4 ml of air
into the thorax via percutaneous route with a 22 gauge
cannula which was placed in the right hemithorax.
The adequacy of the pneumothorax was confirmed with
control X-rays in all groups (figure 1a). Thereafter, the ani-
mals were allowed to survive for an additional 72 h. Anal-
gesia was obtained by using buterfenol (0,5 mg/kg sc).
After 72 hours, in all rats, pneumothorax was immediately
recovered by aspiration with a 22 gauge cannula. The ade-
quacy of the reexpancion was confirmed with control X-
rays (figure 1b) at onset and after 72 hours by sternotomy
in all groups. All rats were sacrificed by giving lethal dose
of xylazine and ketamine 2 hours after reexpancion of pul-
monary. Their chest was opened by median sternotomy.
Then, the lungs were removed immediately for his-
topathological and histochemical evaluation. His-
topathological samples of lungs were fixed in 10%
buffered formaldehyde. Histochemical samples were kept
in liquid nitrogen for oxidative stress status analysis.
The pneumothorax and reexpancion were confirmed with  control X-rays in all groups, (a) We ensured the pneumoth- orax by X-ray graphs (b) Chest X-ray confirmed right re- expansion Figure 1
The pneumothorax and reexpancion were confirmed 
with control X-rays in all groups, (a) we ensured the 
pneumothorax by X-ray graphs (b) chest X-ray con-
firmed right re-expansion.Journal of Cardiothoracic Surgery 2008, 3:57 http://www.cardiothoracicsurgery.org/content/3/1/57
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Tissue preparation for histopathological evaluation
After fixing in 10% buffered formaldehyde the lung sam-
ples were embedded in paraffin blocks. 4 μm sections
were sliced from paraffin blocks and stained with hema-
toxylin-eosin (HE). Pulmonary edema was evaluated by
blinded two pathologists for the research. The frozen tis-
sues were homogenized in phosphate buffer (pH 7.4) by
means of a homogenizator (Heidolph Diax 900; Hei-
dolph Elektro GmbH, Kelhaim, Germany). The superna-
tant was divided into 2–3 parts, put in separate tubes, and
stored at -70°C.
Tissue preparation for oxidative stress status
We used the same methods that Ucar et al had previously
used in determining oxidative stress and antioxidant
enzymes [12]. Since we had to express the data we had as
per tissue protein, we assayed the protein content of the
lung. With the thiobarbituric acid (TBA) reaction lipid
peroxidation was measured. In this method, during the
reaction of thiobarbituric acid (TBA) with malondialde-
hyde (MDA) at 535 nm a color was produced and this was
used to obtain a spectrophotometric measurement. We
reported the final estimated MDA levels in mmol/g-pro-
tein in lung tissue. We determined the cupper/zinc-super-
oxide dismutase (Cu/Zn-SOD) activity with the nitroblue
tetrazolium (NBT) method. In this method NBT is
reduced to formazan by the superoxide radical (O-2) and
this compound has a strong absorbance at 560 nm. In this
study, one unit (U) of Cu/Zn-SOD means the amount of
protein that inhibits the rate of NBT reduction by 50%. U/
g-protein was used to express the calculated enzyme activ-
ity. Glutathione peroxidase (GPx) activity was assessed
with the method where GPx is coupled via the oxidation
of NADPH by glutathione reductase. With a spectropho-
tometer, the oxidation of NADPH had been followed up
at 37°C for 5 minutes, and the absorbance at 340 nm was
recorded. Since mmol of NADPH oxidized per minute
formed a line in the graphic, the slope of the line meant
us the activity. U/g-protein is used for GPx activity.
Statistical analysis
In the statistical procedure of our study we used Duncan
test besides one-way analysis of variance, and all these sta-
tistical analyses had been performed by statistical software
package SPSS 11.0 for Windows. We used Kruskal-Wallis
and Mann-Whitney U tests to statistically analyse the each
group mutually. We stated the histopathological and his-
tochemical results as the median (min-max) where p <
0.05 was found statistically significant.
Results
Histopathological evaluation
The final results of the performed histophatological exam-
ination were; normal pulmonary parenchyma, fluid
extravasations, fluid extravasations with fluid in the alve-
oli and pulmonary edema. Where these findings represent
a pulmonary edema, the extravasation of fluid is the most
common finding in histophatological examination. The
results of this histopathological examination are pre-
sented in table 1.
The most noticeable finding is real reexpantion pulmo-
nary edema and it occurred in only two animals in the
RPEG group. The severity of the pulmonary edema was
significantly reduced in the Taurine administrated group.
Real reexpantion pulmonary edema's characterization
includes severe pulmonary edema with alveolar damage
and acute inflammation. Various severity levels of reex-
pantion pulmonary edema are shown at the figure 2. In
RPEG group animals, accumulations of alveolar macro-
phages with sparse neutrophilic infiltrate at the alveolar
and interstitial edema regions are indicated.
MDA levels, GPx and SOD activities in tissue
Oxidative stress status analysis included MDA level, SOD
and GPx activity. RPE caused increased MDA levels, and
decreased GPx and SOD activity significantly in lung tis-
sue (P < 0.05) (Table 2). Taurine treatment decreased
MDA levels and increased SOD and GPx activities com-
pared with RPEG (P < 0.05). MDA in RPEG was much
higher than that in TG (P < 0.05). In addition, SOD and
GPx activities in TG were approximately as same as activi-
ties of those in Group CG (P > 0.05).
Discussion
There are some studies about reinflation of a collapsed
lung can lead to pulmonary edema of the reexpanded
lung [5]. RPE has a mortality rate changing from 0% to
20% [3,13]. Some of the patients' conditions who had
severe RPE further deteriorated leading to bradycardia,
hypotension, cardiopulmonary arrest and death [4].
There are some studies about causes of RPE [2]. It is
emphasized that the most important reason of RPE is the
prolonged collapse of a lung for 72 hours before reexpan-
cion [2]. In the light of these knowledge, in our study, we
kept the lungs collapsed for 72 hours to develop RPE. Re-
Table 1: Histopathology results of the groups.
CG RPEG TG
n1 0 1 0 1 0
Normal Pulmonary Parenchyma 10 0 4β, μ
Fluid Extravasations 0 2 α 4μ
Fluid Extravasations with Fluid In The Alveoli 0 6α 2β
Real reexpancion Pulmonary Edema 0 2α 0β
CG; Control Group, RPEG; Re-expansion Pulmonary Edema Group, 
TG; Taurine Treatment Group. α:   p < 0,05, RPEG compared with 
CG; β: p < 0,05, TG compared with RPEG, μ: p < 0,05, TG compared 
with CG.Journal of Cardiothoracic Surgery 2008, 3:57 http://www.cardiothoracicsurgery.org/content/3/1/57
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expansion of a collapsed lung increases the microvascular
permeability and causes reexpansion pulmonary edema
[5,14]. Neutrophils and their products have been impli-
cated in the development of this phenomenon [14]. There
is a large body of evidence that reactive oxygen species
produced during RPE play a key role in lung damage and
endothelial dysfunction [15]. It was suggested that anti-
oxidants might play a role in the treatment of RPE. Tau-
rine is known to be a potent antioxidant and a membrane-
stabilizing agent. Therefore; we investigated whether tau-
rine has a possible beneficial effect in RPE in rats.
(a) Fluid extravasation in the perivascular areas, (HEx200), (b) Esinophilic fluid accumulation in some of the alveolar spaces  (HEx100), (c) Severe pulmonary edema with alveolar damage and scattered typical acute inflamatory cells in RPE (HEx400),  (d) Severe pulmonary edema with alveolar damage and scattered typical acute inflamatory cells in RPE (HEx200) Figure 2
(a) fluid extravasation in the perivascular areas, (HEx200), (b) esinophilic fluid accumulation in some of the 
alveolar spaces (HEx100), (c) severe pulmonary edema with alveolar damage and scattered typical acute 
inflamatory cells in RPE (HEx400), (d) severe pulmonary edema with alveolar damage and scattered typical 
acute inflamatory cells in RPE (HEx200).
Table 2: Oxidative stress related parameters of the groups.
Groups n MDA (nmol/g)
Mean ± Std. Deviation
SOD (U/g)
Mean ± Std. Deviation
GPx
Mean ± Std. Deviation
CG 10 1,45 ± 0,21 654,48 ± 98,48 24,94 ± 1,94
RPEG 10 1,78 ± 0,12 α 585,32 ± 97,14 α 20,44 ± 1,53 α
TG 10 1,63 ± 0,32 β 655,32 ± 112,11 β, μ 23,85 ± 2,46 β
Contrtol group (CG), RPEG Reexpancion Pulmonary Group and Taurine groups (TG) lung tissues. MDA; Malondialdehyde, SOD; Superoxide 
Dismutase. α: p < 0,001, RPEG compared with CG; β: p < 0,05, TG compared with RPEG, μ: p < 0,05, TG compared with CG.Journal of Cardiothoracic Surgery 2008, 3:57 http://www.cardiothoracicsurgery.org/content/3/1/57
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Previous studies demonstrated that administration of tau-
rine, vitamin C, and vitamin E partially protected from
oxidative damage and while all substances had antioxi-
dant effects, only taurine showed morphological protec-
tion in surviving cells [16]. Other studies have
demonstrated that addition of taurine to St. Thomas' car-
dioplegic solution, improved cardiac function recovery
for prolonged hypothermic rat heart preservation by sup-
pressing DNA oxidative stress and cell apoptosis [17].
Besides this, another study have emphasized that treat-
ment with taurine reduces iron-mediated myocardial oxi-
dative stress, preserves cardiovascular function, and
improves survival in iron-overloaded mice. Oudit et al
revealed the role of taurine in protecting reduced glutath-
ione levels that provides an important mechanism by
which oxidative stress-induced myocardial damage can be
curtailed [18]. All these studies made us choose taurine to
use as a potent antioxidant against RPE.
Sivrikoz et al reported that lung is the largest reservoir for
monocytes, macrophages and PNLs. In their study, lym-
phocyte (++) dominance was found semi-quantitatively
at the end of the pnomothorax. Together with reexpan-
cion, lymphocyte levels were increased (+++) and PNLs
started to remigrate to the area. They empahsized that the
reperfusion achieved during reexpancion increases the
production of free radicals by activating the inflammatory
cells in addition to increasing the oxygen supply to the tis-
sue [1].
Saito et al revealed that they therefore believe ROS pro-
duced by xanthine oxidase in endothelial and alveolar
type II cells, plays a major role in the pathogenesis of RPE
[19].
Doerschunk et al demonstrated that histological examina-
tion of the injured right lungs in control animals has focal
areas of edema; hemorrhage in both the alveolar spaces
and the interstitium. There was lymphatic dilatation and
edema within the bronchovascular bundle. They founded
that alveolar macrophages containing cytoplasmic gran-
ules were more in number than PML which are sparse in
the injured lung [5].
In our study, the most common histophatological find-
ings in all groups were fluid extravasations with fluid in
the alveoli. The other important finding was a real pulmo-
nary edema. It is very important to improve ARDS [15].
Because of ineffective treatment, developed ARDS is very
mortal complication. In RPEG group animals, accumula-
tions of alveolar macrophages with sparse neutrophilic
infiltrate at the alveolar and interstitial edema regions are
indicated.
There is a large body of evidence that reactive oxygen spe-
cies (ROS) produced during RPE play a crucial role in lung
damage and endothelial dysfunction [1]. Therefore, oxi-
dative stress parameters like MDA level, SOD and GPx
activities in rats were determined following taurine treat-
ment. RPE caused significantly increased MDA levels, and
decreased GPx and SOD activity in lung tissue in our
study. On the other hand, taurine treatment increased
SOD activity and decreased MDA levels. Taurine was
found to be effective in reducing malondialdehyde levels
also.
Treatment of RPE is supportive [4]. New drugs has been
studied to avoid or to treat reexpansion edema [4]. Ibu-
profen and misoprostol are routinely used for their anti
inflammatory and cell protecting effects in the clinical
practice [20]. The use of monoclonal antibodies pre-
vented neutrophilin filtration and acute pulmonary lesion
induced by the reperfusion ischemia process [21]. It is
suggested that the use of monoclonal antibodies in high
risk patients could be an effective in protective therapy
[21]. In our study, because it is a strong antioxidant agent,
we used taurine for preventing and treatment of RPE.
Briefly, the purpose of using taurine in the diagnostic
hypothesis during the initial symptom phases is protect-
ing or reducing the risk of developing of lesions that lead
RPE. We demonstrated the beneficial effect of taurinee in
preventing the pulmonary edema in hystopathological
examination.
Our study presented that taurine administration has use-
ful effects against the lung injury after reexpancion. The
mechanisms of the protective effects of taurine may be
related to the decrease of MDA level and the increase of
SOD and GPx activity. This experimental study shows that
supplementation of taurine is safe and seems to have pos-
itive influence on the subjects with RPE. Although we
indicated that taurine might be effective in preventing,
protecting and in the treatment of RPE, further studies are
needed to be done about this subject. For this reason, we
are planning some consecutive studies related with the
topics: 1) Proper treatment dosage 2) Suitable administra-
tion way of taurine, and 3) Most appropriate treatment
interval time.
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